Skip to main navigation
Skip to Navigation Skip to Content
Mediclinic InternationalMediclinic International

 

  • Careers
  • Contact
  • Sustainable Development
  • Results Centre
  • News
  • Sustainable Development
  • Results Centre
  • News
Search
Hirslanden Home

Header Links Bottom

  • Sustainable Development
  • Results Centre
  • News

Sidebar Links - Middle

  • About Us
  • Clinical Services
  • Our Operations
  • Governance
  • Investor Relations
  • Media & News

Header Links Top

  • Careers
  • Contact
Hirslanden Home

Sidebar Right Links

About UsAbout Mediclinic InternationalStrategic OverviewPurpose, Vision and ValuesBoard of DirectorsExecutive Management
Clinical Services
Our OperationsOperating DivisionsHirslanden - SwitzerlandMediclinic Southern AfricaMediclinic Middle East
Our InvestmentsSpire Healthcare Group - UK
GovernanceGovernance OverviewBusiness Conduct & EthicsCorporate GovernanceRisk Management
Investor RelationsInvestor Overview
Share PerformanceShare ChartShare CalculatorShare Price Lookup
Results CentreResults and ReportsPresentations and Investor Days
Regulatory News
Offer for Mediclinic International plc
Investment Case
Investor CalendarUpcoming EventsPast Events
FinancialsFive-Year SummaryAnalystsDownloads
Shareholder CentreShareholder MeetingsDividendsRegistrarsCirculars & ProspectusesCombination of Mediclinic and AI NoorShareholder Privacy
Investor ContactInvestor RelationsCompany InformationInformation RequestsEmail AlertsCompany Advisors
Media & NewsMedia CentreNews & StoriesSocial MediaMedia Kit
Careers
Shareholder Centre

Combination of Mediclinic and Al Noor

Shareholder Meetings Dividends RegistrarsCirculars & ProspectusesCombination of Mediclinic and AI NoorShareholder Privacy

Combination of Mediclinic and Al Noor

Issued by Mediclinic (pre-takeover)

POTENTIAL TAX IMPLICATIONS OF MEDICLINIC SCHEME FOR MEDICLINIC SA SHAREHOLDERS
22/02/2016
Name change to Mediclinic International plc effective
15/02/2016
Completion Announcement
15/02/2016
Al Noor Pre-listing Announcement – secondary inward listing of Al Noor on the main board of the JSE
02/02/2016
Competition Tribunal approval, recovery of dividends tax on Repurchase Option and finalisation announcement
29/01/2016
Update on competition process and revised expected timetable
20/01/2016
Presentation: Capital Markets Day
19/01/2016
Recording of Capital Markets Day presentations
19/01/2016
Results of the Mediclinic Scheme Meeting
15/12/2015
Results of the Takeover Special Committee Ruling concerning Remgro Healthcare
15/12/2015
Al Noor Prospectus to Al Noor shareholders
03/12/2015
Al Noor Circular to Al Noor shareholders
03/12/2015
Consent letter from KPMG
19/11/2015
Al Noor Prospectus in terms of South African Companies Act to Mediclinic shareholders
17/11/2015
Mediclinic Scheme Circular to Mediclinic shareholders
17/11/2015
Announcement regarding posting of Scheme Circular and notice of Scheme Meeting
17/11/2015
Investor presentation
14/10/2015
Recording of interviews with CEOs of Al Noor and Mediclinic
14/10/2015
Recommendation regarding combination of Al Noor and Mediclinic
14/10/2015
Link to live webcast (9:00 UK time / 10:00 SA time)
14/10/2015
Cautionary announcement
06/10/2015
Announcement regarding possible combination of Mediclinic and Al Noor
06/10/2015
Circular relating to rights issue
08/03/2015

Issued by Al Noor (pre-takeover)

Notification of statement of circumstances by KPMG LLP regarding change of auditors
04/03/2016
POTENTIAL TAX IMPLICATIONS OF MEDICLINIC SCHEME FOR MEDICLINIC SA SHAREHOLDERS
22/02/2016
Change of accounting reference date and auditor
22/02/2016
Second reduction of capital effective
17/02/2016
Completion Announcement
15/02/2016
Name change to Mediclinic International plc effective
15/02/2016
Announcement – Combination Unconditional
29/01/2016
Announcement – First Reduction of Capital Effective
22/01/2016
Update on Competition Process and Revised Timetable of Principal Events
19/01/2016
Al Noor GM Results Announcement
15/12/2015
Consent letter from PricewaterhouseCoopers LLP
19/11/2015
Assets transfer agreement
19/11/2015
Irrevocable undertaking from Dr Kassem Alom
19/11/2015
Bid Conduct Agreement between Al Noor and Mediclinic
19/11/2015
Publication of Prospectus, Circular and Notice of General Meeting and Trading Update
19/11/2015
Memorandum of incorporation of Remgro Limited
19/11/2015
Proposed amendments to the articles of association of the Company
19/11/2015
Irrevocable undertaking from KHS Pretorius
19/11/2015
Form of Proxy
19/11/2015
Consent letter from Goldman Sachs International
19/11/2015
Facility Agreement
19/11/2015
Irrevocable undertaking from E DE LA H Hertzog
19/11/2015
Accountants’ and financial advisers’ reports on the Profit Forecast (Extract from Appendix 3 of the Circular)
19/11/2015
Proposed new remuneration policy (extract from Appendix 4 of the Circular)
19/11/2015
Irrevocable undertaking from Remgro
19/11/2015
Subscription Agreement between Al Noor and Remgro
19/11/2015
Class 1 and Whitewash Circular and Notice of General Meeting
19/11/2015
Consent letter from Jefferies
19/11/2015
The Remgro Bridge Facility Agreement
19/11/2015
Irrevocable undertaking from CI Tingle
19/11/2015
Consent letter from KPMG
19/11/2015
Irrevocable undertaking from GC Hattingh
19/11/2015
Irrevocable undertaking from Sheik Mohammed Bin Butti Al Hamed
19/11/2015
Non-Disclosure Agreement between Al Noor, Mediclinic & Remgro
19/11/2015
Unaudited pro forma financial information of the Enlarged Group (Extract from Part VII of the Circular)
19/11/2015
Articles of association of the Company
19/11/2015
Irrevocable undertaking from D P Meintjes
19/11/2015
Relationship Agreement between Al Noor and Remgro
19/11/2015
Prospectus
19/11/2015
Consent letter from N.M. Rothschild & Sons Limited
19/11/2015
Deal Origination Fee
19/11/2015
Irrevocable undertaking from CA Van der Merwe
19/11/2015
Link to live webcast Investor webcast
14/10/2015
Joint Transaction Announcement - English
14/10/2015
Recording of interviews with CEOs of Al Noor and Mediclinic www.mediclinicalnoor.com
14/10/2015
Mediclinic Al Noor Investor Presentation
14/10/2015
Joint Transaction Announcement - Arabic
10/10/2015
Statement regarding possible combination
05/10/2015

Website Notice Block

Email Alert Registration

Would you like to receive regular updates about Mediclinic International events and announcements? Then register for email alerts so we can send you all future updates directly.

Email Alerts

Scroll to Top
Mediclinic LogoHirslanden Home
Mediclinic International
  • About Mediclinic International
  • Our Operations
  • Governance
  • Investor Relations
  • Media & News
  • Careers
Contact
© Mediclinic International
Modern Slavery Statement
Terms of Use
Privacy Statement
Cookie Policy